How Endress+Hauser helps customers to improve their products and manufacture them even more efficiently.
American meteorologist Edward Lorenz brought chaos theory into the public consciousness with his notion that a butterfly flapping its wings in Brazil can set off a tornado in Texas. That same concept applies equally to supply chains, where even seemingly insignificant glitches can have major repercussions.
AI doesn’t always have to be the answer. A multi-sensor system such as the QWX43 fermentation monitor supplies data to conventional, cloud-based algorithms – another way for users to benefit from digitalization. Microbrewer Armin Pillmeier uses real-time analysis for precise control of fermentation processes.
In an increasingly complex world, Endress+Hauser is taking steps to open up to people and organizations outside the company in a collaborative search for innovations. The approach has already made it possible to quickly gain ground in the field of AI.
Artificial intelligence will fundamentally change how people work and how companies do business – in a good way. Christian Klein, CEO of SAP, is convinced of that. In a joint interview with Endress+Hauser Supervisory Board president Matthias Altendorf, he talks about the transformation required to exploit its potential.
Global climate protection and the associated decarbonization measures are gaining momentum. And it’s not only at the political level: as investors steer global money toward green technologies, entire industries are undergoing fundamental change. For hydrocarbon-dependent process industries, this brings both new challenges and major opportunities. We take stock of the situation.
With its three modernized seaports in Dar es Salaam, Tanga and Mtwara, Tanzania wants to reinforce its role as a major trade center in East Africa. To support this effort, Endress+Hauser is supplying advanced measurement technology – an extraordinary project that turned into a real challenge under pandemic conditions.
CureVac is a pioneer in the development and manufacture of mRNA therapeutics. The company is currently expanding its Covid-19 vaccine production – supported by Endress+Hauser.
The life science industry manager at Endress+Hauser talks about the impact of the Corona pandemic.
11 minutes
